Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Net Income 2008–2025
Vertex Pharmaceuticals Incorporated annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Vertex Pharmaceuticals Incorporated net income for the quarter ending March 31, 2026 was 1.0 B, a 59.59% increase year-over-year.
- Vertex Pharmaceuticals Incorporated net income for the twelve months ending March 31, 2026 was 3.8 B, a 1017.86% decrease year-over-year.
- Vertex Pharmaceuticals Incorporated annual net income for 2025 was 4.0 B, a 838.09% decrease from 2024.
- Vertex Pharmaceuticals Incorporated annual net income for 2024 was -535.6 M, a 114.80% decrease from 2023.
- Vertex Pharmaceuticals Incorporated annual net income for 2023 was 3.6 B, a 8.96% increase from 2022.
- Vertex Pharmaceuticals Incorporated annual net income for 2022 was 3.3 B.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vertex Pharmaceuticals Inc. Net Income — FAQ
Vertex Pharmaceuticals Inc. (VRTX) net income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Vertex Pharmaceuticals Inc.'s net income?
Vertex Pharmaceuticals Inc. (VRTX) reported net income of $3.95B for fiscal 2025.
Where can I see VRTX's net income history?
The chart and table above show Vertex Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.